References
- Saag M., Powderly W., Cloud G., Robinson P., Grieco M., Sharkey P., Thompson S., Sugar A., Tuazon C., Fisher J., Hyslop N., Jacobson J., Hafner R., Dismukes W., NIAID Mycoses Study Group, the AIDS Clinical Trials Group. Comparison of Amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83–89, the
- Holmberg K., Meyer R. Fungal Infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986; 18: 179–192
- Douglas W., Pietroski N., Buckley M., Braffman M., Stern J. (1991) Incidence of cryptococcal meningitis in HIV positive patients with low CD4 cells. VII International Conference on AIDS, Florence, 16–21 June, 1991, (M.C. 3111)
- Perfect R. J. Antifungal prophylaxis: to prevent or not. Am J Med 1993; 94: 233–234
- Bozzette S., Larsen R., Chiu J., Leal M., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J., Tilles J., Leedom J., Richman D., Californian Collaborative Treatment Group. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 580–584, the
- Powderly W., Saag M., Cloud G., Robinson P., Meyer R., Jacobson J., Graybill J., Sugar A., McAuliffe V., Follansbee S., Tuazon C., Stern J., Feinberg J., Hafner R., Dismukes W., NIAID AIDS Clinical Trials Group, the NIAID Mycoses Study Group. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 793–798, the
- Nightingale S., Cal S., Peterson D., Loss S., Gamble B., Watson D., Manzone C., Baker J., Jockusch J. Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992; 6: 191–194
- Pradier C., Bernard E., Lubick C., Toussaint-Gari M., Pinier Y., Durant J., Mondain V., Le Fichoux Y., Dellamonica P. Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients?. J Infect Dis 1992; 165: 787
- Fischl M., Richman D., Grieco M., Gottlieb M., Volberding P., Laskin O., Leedom J., Groopman J., Mildvan D., Schooley R., Jackson G., Durack D., King D., AZT Collaborative Working Group. The efficacy of azidothymidine (Azt) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–197, the